Biotheus Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
300
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$290M
- Investors
-
1
Biotheus General Information
Description
Developer of next generation antibody-based therapeutics. The company studies the mechanisms of TReg cells and innate immunity in cancer, discovers antibody and develops antibody-based therapeutics, enabling patients to have more efficient immunity therapy and drugs for cancer and metabolic diseases.
Contact Information
Website
www.biotheus.comCorporate Office
- Unit 10B, Building 4, No. 1 Keji 7th Road
- Xiang Zhou District, Tangjiawan Town
- Zhuhai, Guangdong 519080
- China
Corporate Office
- Unit 10B, Building 4, No. 1 Keji 7th Road
- Xiang Zhou District, Tangjiawan Town
- Zhuhai, Guangdong 519080
- China
Biotheus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 31-Jan-2025 | $290M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 03-Mar-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 30-Sep-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 26-Jun-2019 | $14.5M | $40.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 29-Oct-2018 | $26.1M | $26.1M | Completed | Generating Revenue |
Biotheus Comparisons
Industry
Financing
Details
Biotheus Competitors (3)
One of Biotheus’s 3 competitors is LakeShore Biopharma, a Formerly PE-Backed company based in San Po Kong, Hong Kong.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LakeShore Biopharma | Formerly PE-Backed | San Po Kong, Hong Kong | ||||
| Regor Therapeutics | Venture Capital-Backed | Shanghai, China | ||||
| Clover Biopharmaceuticals | Formerly VC-backed | Shanghai, China |
Biotheus Patents
Biotheus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026017189-A2 | Anti-il-31 antibody, pharmaceutical composition thereof and use thereof | Pending | 19-Jul-2024 | ||
| WO-2026017189-A3 | Anti-il-31 antibody, pharmaceutical composition thereof and use thereof | Pending | 19-Jul-2024 | ||
| WO-2026017190-A1 | Anti-il-4rα single-domain antibody, fusion protein thereof, pharmaceutical composition thereof and use thereof | Pending | 19-Jul-2024 | ||
| WO-2026017191-A2 | Anti-il-5 antibody, pharmaceutical composition thereof and use thereof | Pending | 19-Jul-2024 | ||
| WO-2026017191-A3 | Anti-il-5 antibody, pharmaceutical composition thereof and use thereof | Pending | 19-Jul-2024 |
Biotheus Signals
Biotheus Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CPE Funds Management | PE/Buyout | Minority | ||
| Cowin Capital | Venture Capital | Minority | ||
| General Atlantic | Growth/Expansion | Minority | ||
| Hanne Capital | Growth/Expansion | Minority | ||
| Highlight Capital | Venture Capital | Minority |
Biotheus FAQs
-
When was Biotheus founded?
Biotheus was founded in 2018.
-
Where is Biotheus headquartered?
Biotheus is headquartered in Zhuhai, China.
-
What is the size of Biotheus?
Biotheus has 300 total employees.
-
What industry is Biotheus in?
Biotheus’s primary industry is Biotechnology.
-
Is Biotheus a private or public company?
Biotheus is a Private company.
-
What is the current valuation of Biotheus?
The current valuation of Biotheus is .
-
What is Biotheus’s current revenue?
The current revenue for Biotheus is .
-
How much funding has Biotheus raised over time?
Biotheus has raised $40.5M.
-
Who are Biotheus’s investors?
CPE Funds Management, Cowin Capital, General Atlantic, Hanne Capital, and Highlight Capital are 5 of 11 investors who have invested in Biotheus.
-
Who are Biotheus’s competitors?
LakeShore Biopharma, Regor Therapeutics, and Clover Biopharmaceuticals are competitors of Biotheus.
-
When was Biotheus acquired?
Biotheus was acquired on 31-Jan-2025.
-
Who acquired Biotheus?
Biotheus was acquired by BioNTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process